Emery-Dreifuss muscular dystrophy (EDMD) |
X- linked recessive disorder, Emerin (STA) mutation [45]
Mutation in Lamin A/C produced by the alternate splicing of LMNA gene [46]
|
Mandibuloacral dysplasia and partial lipodystrophy |
Homozygous missense mutation, Arg527His, in LMNA gene. Muation in ZMPSTE24 [47] |
Mandibuloacral dysplasia with type A lipodystrophy (MADA) |
Homozygous mutation in R527H in the LMNA gene [48] |
Restrictive dermopathy (RD) |
Dominant de novo
LMNA mutations, recessive ZMPSTE24 [FACE-1 in humans] mutations (either homozygous or heterozygous), both within exon 9 [49]
RD with ZMPSTE4 mutation—a complete absence of Lamin A protein—also a factor to identify lethal neonatal laminopathy
|
Hutchinson- Gilford progeria syndrome (HGPS) |
Single point mutation in LMNA gene causing production of permanently farnesylated mutant Lamin A protein, progerin [50] (p. 22)
Recurrent de novo single-base substitution within exon 11 of LMNA [51]
|
Limb Girdle muscular dystrophy type 1B (LGMD1B) |
Mutation linked to the chromosome 1q11-q21 of LMNA gene [43] |
Dilated cardiomyopathy (DCM) |
R89L, 959delT, R337H, S573L mutation in LMNA [52,53] |
Autosomal recessive axonal Charcot-Marie-Tooth type 2 (CMT2) |
R298C mutation in lamin A/C [54] |
Dunnigan type familial partial lipodystrophy (FPLD) |
R482Q mutation in lamin A/C, mutation in the gene mapped to chromosome 1q21-22 encoding for the LMNA gene [55] |
Adult autosomal dominant leukodystrophy (movement disorder) |
Associated with increase or accumulation of lamin B1 [56] |
Primary microcephaly (neuro—developmental disorder) |
Heterozygous dominant pathogenic variants in both lamin B1 and lamin B2 [57] |
Progressive myoclonus epilepsy including the early identification of ataxia |
Rare and novel homozygous missense p.His157Tyr mutation in the alpha- helical rod of the lamin B2 protein [58] |
Acquired partial lipodystrophy (APL) |
Mutation in the LMNB2 gene on 19p13.3 might be the cause of this disease [59] |